Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· June 22, 2026

Abaxx Continues to Provide Facts Refuting Ongoing Misinformation and Reaffirms Strong Business Fundamentals

View original at globenewswire.com
Abaxx Continues to Provide Facts Refuting Ongoing Misinformation and Reaffirms Strong Business Fundamentals Neither the Company nor its subsidiaries are under investigation by any regulatorUrges CIRO to investigate potentially manipulative or deceptive trading activity in Abaxx’s common sharesRetains leading U.S…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • New exchange markets exhibit natural growth patterns including low open interest relative to volume and trading dominated by incentive program participants building initial liquidity

    60% confidence
  • Through June 19, 2026, the average daily volume on Abaxx Exchange for June was 16,846 contracts per day, a 12% increase from May's 15,092

    60% confidence
  • Average daily open interest on Abaxx Exchange for June was 1,343, a 232% increase from May's 405

    60% confidence
  • None of the participants in Abaxx Exchange's market making and liquidity provider programs are undisclosed related parties

    60% confidence
  • Viceroy's reports amount to a short-and-distort campaign with the sole purpose of profiting from a decline in Abaxx's common share price at the expense of long-term shareholders

    60% confidence
  • Current cash is sufficient to fund operational plans for approximately the next seven quarters without raising additional funds

    60% confidence
  • Wash trading is illegal and not permitted on Abaxx Exchange pursuant to Rule 508 in the Exchange's rulebook

    60% confidence
  • Abaxx Exchange has a robust market surveillance program that actively monitors trading for signs of wash trading or market manipulation in alignment with regulatory requirements

    60% confidence
  • There are now 11 ISVs connected to Abaxx Exchange with 5 more in the pipeline

    60% confidence
  • The current net cash burn rate has averaged C$12.3 million over the past 2 completed quarters

    60% confidence
  • The Company holds more than C$97 million in cash and cash equivalents as of June 2026

    60% confidence
  • There are now 7 clearing firms connected to Abaxx Exchange with 14 more in the pipeline

    60% confidence
  • There are currently 22 brokers connected to Abaxx Exchange with 10 more in the pipeline

    60% confidence
  • Neither the Company nor its subsidiaries are under investigation by any regulator

    60% confidence
  • Suspected violations are subject to Abaxx Exchange's disciplinary proceedings under Rule 209, which can include reporting to regulators and suspension or termination of offending parties

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com
Abaxx Continues to Provide Facts Refuting Ongoing Misinformation and Reaffirms Strong Business Fundamentals — Source | Via News | ViaNews Market